Abstract
Introduction
While presepsin has shown promise as a sepsis biomarker, it has only recently been considered in the field of orthopedic surgery. Therefore, the present review evaluates the role of presepsin in total joint arthroplasty (TJA) as well as its diagnostic and prognostic value in diagnosing PJI.
Methods
Utilizing 4 online databases, we thoroughly searched the literature for articles evaluating the role of presepsin in TJA as well as its prognostic and diagnostic value for PJI.
Results
Studies evaluating perioperative presepsin trends in primary TJA demonstrated that its natural course is similar to C-Reactive Protein (CRP). The area under (AUC) the receiver operating characteristic curves values for serum presepsin ranged from 0.86 to 0.926. These values were higher than the AUCs for CRP in each of their respective studies. However, synovial presepsin demonstrated a lower AUC (0.41). Prognostically, presepsin demonstrated potential in terms of infection monitoring following revision TJA for PJI.
Conclusion
Although the data remains limited, presepsin may serve as a potential biomarker to evaluate the natural inflammatory response following TJA as well as to help diagnose PJI. The present review serves to set the foundation for future study into serum presepsin in larger patient cohorts. Further study is needed to evaluate how this biomarker compares to other laboratory values traditionally used for PJI diagnosis.
Similar content being viewed by others
References
Leta TH, Lygre SHL, Schrama JC et al (2019) Outcome of revision surgery for infection after total knee arthroplasty: results of 3 surgical strategies. JBJS Rev 7:e4. https://doi.org/10.2106/JBJS.RVW.18.00084
Gundtoft PH, Pedersen AB, Varnum C, Overgaard S (2017) Increased mortality after prosthetic joint infection in primary THA. Clin Orthop Relat Res 475:2623–2631. https://doi.org/10.1007/s11999-017-5289-6
Kurtz SM, Lau EC, Son MS et al (2018) Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the medicare population. J Arthroplasty 33:3238–3245. https://doi.org/10.1016/j.arth.2018.05.042
Natsuhara KM, Shelton TJ, Meehan JP, Lum ZC (2019) Mortality during total hip periprosthetic joint infection. J Arthroplasty 34:S337–S342. https://doi.org/10.1016/j.arth.2018.12.024
Koh CK, Zeng I, Ravi S et al (2017) Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: an analysis of 11,134 knees. Clin Orthop Relat Res 475:2194–2201. https://doi.org/10.1007/s11999-017-5396-4
Jämsen E, Huhtala H, Puolakka T, Moilanen T (2009) Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 91:38–47. https://doi.org/10.2106/JBJS.G.01686
Delanois RE, Mistry JB, Gwam CU et al (2017) Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty 32:2663–2668. https://doi.org/10.1016/j.arth.2017.03.066
Gwam CU, Mistry JB, Mohamed NS et al (2017) Current epidemiology of revision total hip arthroplasty in the United States: national inpatient sample 2009 to 2013. J Arthroplasty 32:2088–2092. https://doi.org/10.1016/j.arth.2017.02.046
American Joint Replacement Registry (AJRR) (2020) In: The seventh annual report of the AJRR on hip and knee arthroplasty
Patel A, Pavlou G, Mújica-Mota RE, Toms AD (2015) The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. a study using the national joint registry dataset. Bone Jt J 97-B:1076–1081. Doi: https://doi.org/10.1302/0301-620X.97B8.35170/ASSET/IMAGES/LARGE/35170-GALLEYFIG4B.JPEG
Kurtz SM, Lau E, Watson H et al (2012) Economic burden of periprosthetic joint infection in the united states. J Arthroplasty 27:61–65. https://doi.org/10.1016/j.arth.2012.02.022
George J, Jawad M, Curtis GL et al (2018) Utility of serological markers for detecting persistent infection in two-stage revision arthroplasty in patients with inflammatory arthritis. J Arthroplasty 33:S205–S208. https://doi.org/10.1016/j.arth.2017.12.018
Shukla SK, Ward JP, Jacofsky MC et al (2010) Perioperative testing for persistent sepsis following resection arthroplasty of the hip for periprosthetic infection. J Arthroplasty 25:87–91. https://doi.org/10.1016/j.arth.2010.05.006
Hoell S, Moeller A, Gosheger G et al (2016) Two-stage revision arthroplasty for periprosthetic joint infections: What is the value of cultures and white cell count in synovial fluid and CRP in serum before second stage reimplantation? Arch Orthop Trauma Surg 136:447–452. https://doi.org/10.1007/s00402-015-2404-6
Yoon H-K, Cho S-H, Lee D-Y et al (2017) A review of the literature on culture-negative periprosthetic joint infection: epidemiology, diagnosis and treatment. Knee Surg Relat Res 29:155. https://doi.org/10.5792/KSRR.16.034
Shahi A, Kheir MM, Tarabichi M et al (2017) Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation. J Bone Joint Surg Am 99:1419–1427. https://doi.org/10.2106/JBJS.16.01395
Warren J, Anis HK, Bowers K et al (2021) Diagnostic utility of a novel point-of-care test of calprotectin for periprosthetic joint infection after total knee arthroplasty: a prospective cohort study. J Bone Joint Surg Am 103:1009–1015. https://doi.org/10.2106/JBJS.20.01089
Zhang J, Hu Z De, Song J, Shao J (2015) Diagnostic value of presepsin for sepsis: A systematic review and meta-analysis. Med. (United States) 94:e2158
Anemüller R, Belden K, Brause B et al (2019) Hip and knee section, treatment, antimicrobials: proceedings of international consensus on orthopedic infections. J. Arthroplasty 34:S463–S475
Yaegashi Y, Shirakawa K, Sato N et al (2005) (2005) Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 115(11):234–238. https://doi.org/10.1007/S10156-005-0400-4
Wu CC, Lan HM, Han ST et al (2017) Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care 7:1–16. https://doi.org/10.1186/s13613-017-0316-z
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:105906. https://doi.org/10.1136/BMJ.N71
Bastian D, Tamburstuen MV, Lyngstadaas SP, Reikerås O (2011) LBP and sCD14 patterns in total hip replacement surgery performed during combined spinal/epidural anaesthesia. Scand J Clin Lab Invest 71:486–491. https://doi.org/10.3109/00365513.2011.587529
Vicenti G, Di Bari P, Pesce V, Carrozzo M Perioperative plasmatic presepsin levels in patients undergoing total hip or knee replacement: a preliminary study Basic Medical Sciences Evolution in Orthopaedics View project
Marazzi MG, Randelli F, Brioschi M et al (2018) Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers. Int J Immunopathol Pharmacol 31:0394632017749356. https://doi.org/10.1177/0394632017749356
Imagama T, Tokushige A, Seki K et al (2019) Early diagnosis of septic arthritis using synovial fluid presepsin: a preliminary study. J Infect Chemother 25:170–174. https://doi.org/10.1016/j.jiac.2018.10.015
Busch A, Jäger M, Engler H, et al (2020) Diagnostic Accuracy of Synovial Neopterin, TNF-α and Presepsin in Periprosthetic Joint Infection: a Prospective Study. Z Orthop Unfall. Doi: https://doi.org/10.1055/A-1303-5105
Whiting PF, Rutjes AWS, Westwood ME et al (2011) Quadas-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
Li C, Renz N, Trampuz A, Ojeda-Thies C (2020) Twenty common errors in the diagnosis and treatment of periprosthetic joint infection. Int Orthop 44:3. https://doi.org/10.1007/S00264-019-04426-7
Keemu H, Vaura F, Maksimow A et al (2021) Novel biomarkers for diagnosing periprosthetic joint infection from synovial fluid and serum. JBJS Open Access 6:11. https://doi.org/10.2106/JBJS.OA.20.00067
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
A.F.K. reports the following disclosures: research support (Signature Orthopaedics), paid presenter or speaker (DePuy Synthes and Zimmer Biomet), paid consultant (DePuy Synthes and Zimmer Biomet), stock or stock options (Zimmer Biomet, Johnson & Johnson, and Procter & Gamble), IP royalties (Innomed), and board or committee member (AAOS, AAHKS, and Anterior Hip Foundation). M.L.D., A.J.A., and L.T.S. have nothing to disclose.
Ethical standards
We certify that our analysis complies with the ethical standards of our institution as well as laws related to research conducted in the USA.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Delva, M.L., Samuel, L.T., Acuña, A.J. et al. Presepsin as a diagnostic biomarker of peri-prosthetic joint infection: a review of the literature. Eur J Orthop Surg Traumatol 33, 695–700 (2023). https://doi.org/10.1007/s00590-022-03232-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-022-03232-z